Ann: IHL commences IHL-675 (ARDS) animal study, page-36

Agreed E but still think SAARDS / COVID will be the game changer for us by virtue of the fact we could potentially be granted FDA emergency use authorisation - this would be big news on a GLOBAL scale, not that the other trials wouldn't be, but doctors will be able to start prescribing this from day 1 and to say that this would lift the profile of the company would be the understatement of the year; this trial has taken precedence over the other trials for very good reason.

I think we're in a good space when we're debating about which initiative will MAKE the company